A series
of heteroleptic square-planar Pt and Pd complexes with
bis(diisopropylphenyl) iminoacenaphtene (dpp-Bian) and Cl, 1,3-dithia-2-thione-4,5-dithiolate
(dmit), or 1,3-dithia-2-thione-4,5-diselenolate (dsit) ligands have
been prepared and characterized by spectroscopic techniques, elemental
analysis, X-ray diffraction analysis, and cyclic voltammetry (CV).
The intermolecular noncovalent interactions in the crystal structures
were assessed by density functional theory (DFT) calculations. The
anticancer activity of Pd complexes in breast cancer cell lines was
limited by their solubility. Pd(dpp-Bian) complexes with dmit and
dsit ligands as well as an uncoordinated dpp-Bian ligand were devoid
of cytotoxicity, while the [Pd(dpp-Bian)Cl2] complex was
cytotoxic. On the contrary, all Pt(dpp-Bian) complexes demonstrated
anticancer activity in a low micromolar concentration range, which
was 8–20 times higher than the activity of cisplatin, and up
to 2.5-fold selectivity toward cancer cells over healthy fibroblasts.
The presence of a redox-active dpp-Bian ligand in Pt and Pd complexes
resulted in the induction of reactive oxygen species (ROS) in cancer
cells. In addition, these complexes were able to intercalate into
DNA, indicating the dual mechanism of action.